James R. McNab, Director at TITAN PHARMACEUTICALS INC (TTNP), bought 32,726 shares at $3.16 ($103K) on 2016-01-13, disclosed to the SEC on 2016-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.16 | 16,363 | $52K | 50.0% |
| 2 | $3.16 | 16,363 | $52K | 50.0% |
| Total | $3.16 avg | 32,726 | $103K | 100% |
| Filing → |
| CRIS | SELL | 2017-05-02 | $466K | — | Filing → |
| CRIS | SELL | 2017-04-27 | $618K | — | Filing → |
| CRIS | SELL | 2017-04-27 | $571K | — | Filing → |